Boehringer Ingelheim Vetmedica has launched a unique and natural muscle building supplement for horses, Equitop Myoplast Power Pearls, containing 18 key amino acids.

The company says maintaining muscular condition in performance and sports horses can…

Boehringer Ingelheim Vetmedica has launched Prascend, the first licensed product for the treatment of Pituitary Pars Intermedia Dysfunction (PPID) in horses, commonly known as Equine Cushing's Disease.

Prascend contains pergolide mesylate, and…

Boehringer Ingelheim Vetmedica has launched a series of information sheets written by veterinary surgeons, nutritionists and leading riders to support its muscle building supplement for horses, Equitop Myoplast Power Pearls.

Available to download as PDFs…

Boehringer Ingelheim Vetmedica, manufacturer of the equine pergolide Prascend, has joined forces with the British Horse Society, Redwings Horse Sanctuary and World Horse Welfare to launch the 'Talk About Cushing's (TAC)' campaign.

The initiative…

Boehringer Ingelheim VetMedica has published its equine endocrine webinars online for veterinary professionals to view on demand at www.prascend.co.uk/webinars.

The webinars, which cover 'Diagnostic challenges in equine endocrine disease', presented…

Boehringer Ingelheim Vetmedica has released data which shows that one third of laminitic middle aged horses (between the ages of 10 and 15 years) test positive for PPID (Cushing's)¹.

Over 3,100 horses were tested for Cushings as part of the company…

Boehringer Ingelheim has announced that its 'Talk About Laminitis' campaign will run from Mid March until the end of June. 

Last year, the initiative saw over 9000 horses and ponies tested for PPID through its free ACTH test scheme. This year…

Boehringer Ingelheim Vetmedica has launched Equisolon 33 mg/g oral powder, the first licensed oral prednisolone for the alleviation of inflammation associated with recurrent airway obstruction (RAO), otherwise known as heaves, in horses.

Clare Turnbull…

Boehringer Ingelheim has launched Care and Connect a free online PPID aftercare service for horse owners, designed to help veterinary practices monitor their PPID case load and streamline the case management process.

The new service is part of Boehringer…

Boehringer Academy has joined forces with Andy Durham from Liphook Equine Hospital to launch a series of short webinars covering recent updates in laminitis laboratory tests and common FAQs on the management of PPID in horses.

The webinars each last…

Boehringer (maker of Buscopan 20) is offering 30 rectal tops in a prize draw for veterinary professionals who watch its Feel Good Colic Rectals (there's an oxymoron if ever I've heard one) online CPD video.

Feel Good Colic Rectals is a 20-minute…

Boehringer Ingelheim, manufacturer of Equisolon, has launched a CPD module on equine lower respiratory tract disease which is delivered in practice.

The module, which accounts for one hour’s CPD, is facilitated by a Boehringer Ingelheim territory manager…

Boehringer Ingelheim is urging veterinary surgeons in the UK to test for PPID routinely at the annual health check or vaccination visit for horses over the age of 15.

The recommendation follows the analysis of data collected as part of the company's…

Boehringer Ingelheim, manufacturer of Prascend, has launched www.careaboutcushings.co.uk, an information resource for horse owners.

The Care About Cushing’s website is designed to give horse owners the information they need to spot the signs of Cushing…

Boehringer Ingelheim has rebranded its equine joint supplement, Seraquin GLME, as Equitop GLME.

Equitop GLME is a palatable, pearl formulation joint supplement developed to support the healthy function of cartilage, joint capsules, tendons and ligaments…

Boehringer Ingelheim, manufacturer of Prascend, has launched an Equine Endocrine Pioneers Circle webinar to provide vets with evidence based and personal opinions of PPID (Pituitary Pars Intermedia Dysfunction) diagnosis, appropriate testing and case management…

Boehringer Ingelheim Animal Health has announced the launch of Arti-Cell Forte, the first stem cell-based veterinary medicine to get marketing authorisation for treating equine lameness, calling it a 'breakthrough medicine for degenerative joint disease…

Boehringer Ingelheim has launched Aservo EquiHaler (ciclesonide inhalation solution), the first inhaled treatment for equine asthma.

The company says the new product has been 10 years in development and uses 'Soft Mist' technology - developed originally…

Boehringer Ingelheim has launched 'Thank You Vets', a new campaign to give horse owners an opportunity to recognise the care and passion equine vets have continued to deliver during the pandemic.

The company is encouraging owners to post a simple…

Boehringer Ingelheim has launched a recycling programme for Aservo EquiHaler, its treatment for equine asthma symptoms.

The company points to research which found that 89% of the veterinary profession wants to play a more active role in the sustainability…

Boehringer Ingelheim has received UK marketing authorisation for RenuTend - the first licensed treatment to improve healing of tendon injuries and suspensory ligaments in horses.

Renutend contains primed mesenchymal stem cells (MSCs) which Boehringer says…